IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Commenc...
January 21 2016 - 6:00PM
Wolf Haldenstein Adler Freeman & Herz LLP announces that a
class action lawsuit has been filed in the United States District
Court for the Southern District of Texas on behalf of all persons
or entities that purchased the securities of Nobilis Health Corp.
(“Nobilis” or the “Company”) (NYSE:HLTH) between April 2, 2015
through January 6, 2016 (the “Class Period”), inclusive.
Shareholders who incurred losses on
shares on purchased within the Class Period are urged to contact
the firm immediately at classmember@whafh.com or
(800) 575-0735 or (212) 545-4774.
If you purchased the shares of Nobilis Health
Corp. during the period April 2, 2015 through January 6, 2016,
inclusive, you may, no later than March 21, 2016,
request that the Court appoint you lead plaintiff of the proposed
class.
On October 9, 2015, Seeking Alpha published an
article describing the AccuraScope procedure’s “questionable
insurability, unsubstantiated success rates, [and] lack of
recognition from” universities, medical bodies, and insurance
companies. The article additionally noted significant accounting
red flags at Nobilis and reported that Nobilis had overstated its
2014 revenues by as much as $36 million. On this news, the price of
Nobilis common stock fell $1.42 per share, or 27% from its closing
price of $5.24 on October 8, 2015 to close at $3.82 per share on
October 9, 2015.
In a January 5, 2016 Form 8-K filed with the
Securities and Exchange Commission (“SEC”), Nobilis disclosed that
its financial statements for the fiscal year ended December 31,
2014, the quarters ended March 31, 2015 and June 30, 2015 and the
financial statements in its updated S-1 registration statement
filed with the SEC on October 23, 2015 could no longer be relied
upon.
Subsequently, on January 7, 2016, Nobilis
announced that Christopher J.Lloyd had resigned as the Company’s
Chief Executive Officer. On this news, Nobilis stock fell $0.63, or
more than 20%, to close at $2.47 on January 7, 2016.
Wolf Haldenstein has extensive experience in the
prosecution of securities class actions and derivative litigation
in state and federal trial and appellate courts across the
country. The firm has attorneys in various practice areas;
and offices in New York, Chicago and San Diego. The
reputation and expertise of this firm in shareholder and other
class litigation has been repeatedly recognized by the courts,
which have appointed it to major positions in complex securities
multi-district and consolidated litigation.
If you wish to discuss this action or have any
questions regarding your rights and interests in this case, please
immediately contact Wolf Haldenstein Adler Freeman & Herz LLP
by telephone at (800) 575-0735, via e-mail at
classmember@whafh.com, or visit our website at www.whafh.com.
All e-mail correspondence should make reference to the “Nobilis
Investigation.”
Attorney Advertising. Prior results do not guarantee or predict
a similar outcome.
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Patrick Donovan, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, donovan@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From May 2024 to Jun 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jun 2023 to Jun 2024